Christy Oliger
Director/Board Member at KARYOPHARM THERAPEUTICS INC.
Net worth: 108 070 $ as of 2024-06-29
Christy Oliger active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2020-08-27 | - |
| Independent Dir/Board Member | 2020-08-27 | - | |
| REPLIMUNE GROUP, INC. | Director/Board Member | 2021-11-30 | - |
| Independent Dir/Board Member | 2021-11-30 | - | |
| LAVA THERAPEUTICS N.V. | Director/Board Member | 2023-03-08 | - |
| VERA THERAPEUTICS, INC. | Director/Board Member | 2024-06-06 | - |
Career history of Christy Oliger
Former positions of Christy Oliger
| Companies | Position | Start | End |
|---|---|---|---|
| RAYZEBIO, INC. | Director/Board Member | 2023-07-31 | 2024-02-25 |
| REATA PHARMACEUTICALS, INC. | Director/Board Member | 2021-04-14 | 2023-09-25 |
| Independent Dir/Board Member | 2021-04-14 | 2023-09-25 | |
| SIERRA ONCOLOGY, INC. | Director/Board Member | 2021-06-01 | 2022-06-30 |
| Independent Dir/Board Member | 2021-06-01 | 2022-06-30 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2016-12-31 | 2020-06-30 |
Training of Christy Oliger
| University of California, Santa Barbara | Undergraduate Degree |
Statistics
International
| United States | 9 |
| Netherlands | 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| RAYZEBIO, INC. | Health Technology |
| VERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
- Stock Market
- Insiders
- Christy Oliger
- Experience
